Thioridazine Induces Major Changes in Global Gene Expression and Cell Wall Composition in Methicillin-Resistant Staphylococcus aureus USA300

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Thorsing, Mette ^a   Klitgaard, Janne K ^a   Atilano, Magda L ^b   Skov, Marianne N ^a   Kolmos, Hans Jørn ^a   Filipe, Sérgio R ^b   Kallipolitis, Birgitte H ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; BETA LACTAM ANTIBIOTIC; CARRIER PROTEIN; CYCLOSERINE; DICLOXACILLIN; FOSFOMYCIN; GLYCINE; MEMBRANE PROTEIN; METICILLIN; PENICILLIN BINDING PROTEIN; PEPTIDOGLYCAN; THIORIDAZINE; VANCOMYCIN; NEUROLEPTIC AGENT;

AMINO ACID SYNTHESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; TRANSCRIPTOMICS; BIOSYNTHESIS; CELL WALL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; STATISTICAL MODEL;

ANTIPSYCHOTIC AGENTS; BETA-LACTAM RESISTANCE; CELL WALL; GENE EXPRESSION REGULATION, BACTERIAL; GLYCINE; LINEAR MODELS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS; PEPTIDOGLYCAN; THIORIDAZINE;

EID: 84877845374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064518     Document Type: Article

References (90)

1. David MZ, Daum RS, (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23: 616-687 23/3/616 [pii];10.1128/CMR.00081-09 [doi].
2. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS, (2003) Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 37: 1050-1058 CID31185 [pii];10.1086/378277 [doi].
3. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, et al. (2008) Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198: 561-570 10.1086/590157 [doi].
4. Nimmo GR (2012) USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 10.1111/j.1469-0691.2012.03822.x [doi].
5. Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, et al. (2006) Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In Vivo 20: 361-366.
6. Klitgaard JK, Skov MN, Kallipolitis BH, Kolmos HJ, (2008) Reversal of methicillin resistance in Staphylococcus aureus by thioridazine. J Antimicrob Chemother 62: 1215-1221 dkn417 [pii];10.1093/jac/dkn417 [doi].
7. Poulsen MO, Jacobsen K, Thorsing M, Kristensen NR, Clasen J, et al. (2012) Thioridazine potentiates the effect of a beta-lactam antibiotic against Staphylococcus aureus independently of mecA expression. Res Microbiol. S0923-2508(12)00152-0 [pii];10.1016/j.resmic.2012.10.007 [doi].
8. Kaatz GW, Moudgal VV, Seo SM, Kristiansen JE, (2003) Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 47: 719-726.
9. Hendrich AB, Wesolowska O, Michalak K (2001) Trifluoperazine induces domain formation in zwitterionic phosphatidylcholine but not in charged phosphatidylglycerol bilayers. Biochim Biophys Acta 1510: 414-425. S0005-2736(00)00373-4 [pii].
10. Hendrich AB, Lichacz K, Burek A, Michalak K, (2002) Thioridazine induces erythrocyte stomatocytosis due to interactions with negatively charged lipids. Cell Mol Biol Lett 7: 1081-1086.
11. Nagappa AN, Kole PL, Srinivas D, Vivek D, Ullas DP, et al. (2005) Role of liquid membrane phenomenon in the biological actions of thioridazine. Colloids Surf B Biointerfaces 43: 21-27 S0927-7765(05)00105-0 [pii];10.1016/j.colsurfb.2005.04.001 [doi].
12. Boshoff HI, Myers TG, Copp BR, McNeil MR, Wilson MA, et al. (2004) The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279: 40174-40184 10.1074/jbc.M406796200 [doi];M406796200 [pii].
13. Weinstein EA, Yano T, Li LS, Avarbock D, Avarbock A, et al. (2005) Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc Natl Acad Sci U S A 102: 4548-4553 0500469102 [pii];10.1073/pnas.0500469102 [doi].
14. Kristiansen JE, Mortensen I, Nissen B, (1982) Membrane stabilizers inhibit potassium efflux from Staphylococcus aureus strain No. U2275. Biochim Biophys Acta 685: 379-382.
15. Enyeart JJ, Biagi BA, Mlinar B, (1992) Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines. Mol Pharmacol 42: 364-372.
16. Kim KS, Kim EJ, (2005) The phenothiazine drugs inhibit hERG potassium channels. Drug Chem Toxicol 28: 303-313 X1VR0T610052P235 [pii];10.1081/DCT-200064482 [doi].
17. Williams JB, Mallorga PJ, Conn PJ, Pettibone DJ, Sur C, (2004) Effects of typical and atypical antipsychotics on human glycine transporters. Schizophr Res 71: 103-112 10.1016/j.schres.2004.01.013 [doi];S092099640400043X [pii].
18. Ratnakar P, Murthy PS, (1993) Trifluoperazine inhibits the incorporation of labelled precursors into lipids, proteins and DNA of Mycobacterium tuberculosis H37Rv. FEMS Microbiol Lett 110: 291-294.
19. Bonde M, Hojland DH, Kolmos HJ, Kallipolitis BH, Klitgaard JK, (2011) Thioridazine affects transcription of genes involved in cell wall biosynthesis in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 318: 168-176 -10.1111/j.1574-6968.2011.02255.x [doi].
20. Wiegand I, Hilpert K, Hancock RE, (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3: 163-175 nprot.2007.521 [pii];10.1038/nprot.2007.521 [doi].
21. Moazed D, Stern S, Noller HF (1986) Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension. J Mol Biol 187: 399-416. 0022-2836(86)90441-9 [pii].
22. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
23. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3 -10.2202/1544-6115.1027 [doi].
24. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
25. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
26. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36.
27. Sugai M, Akiyama T, Komatsuzawa H, Miyake Y, Suginaka H, (1990) Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis. J Bacteriol 172: 6494-6498.
28. Gustafson JE, Berger-Bachi B, Strassle A, Wilkinson BJ, (1992) Autolysis of methicillin-resistant and-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 36: 566-572.
29. Gardete S, Ludovice AM, Sobral RG, Filipe SR, de Lencastre H, et al. (2004) Role of murE in the Expression of beta-lactam antibiotic resistance in Staphylococcus aureus. J Bacteriol 186: 1705-1713.
30. De Jonge BL, Chang YS, Gage D, Tomasz A, (1992) Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J Biol Chem 267: 11248-11254.
31. Filipe SR, Tomasz A, Ligoxygakis P, (2005) Requirements of peptidoglycan structure that allow detection by the Drosophila Toll pathway. EMBO Rep 6: 327-333 7400371 [pii];10.1038/sj.embor.7400371 [doi].
32. Pannee J, Portelius E, Oppermann M, Atkins A, Hornshaw M, et al. (2012) A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of Abeta38, Abeta40, and Abeta42 in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls. J Alzheimers Dis. D39530N6V88742T1 [pii];10.3233/JAD-2012-121471 [doi].
33. Muthaiyan A, Silverman JA, Jayaswal RK, Wilkinson BJ, (2008) Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother 52: 980-990 AAC.01121-07 [pii];10.1128/AAC.01121-07 [doi].
34. Lama A, Pane-Farre J, Chon T, Wiersma AM, Sit CS, et al. (2012) Response of Methicillin-Resistant Staphylococcus aureus to Amicoumacin A. PLoS One 7: e34037 10.1371/journal.pone.0034037 [doi];PONE-D-11-22250 [pii].
35. Bernal P, Lemaire S, Pinho MG, Mobashery S, Hinds J, et al. (2010) Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem 285: 24055-24065 M110.114793 [pii];10.1074/jbc.M110.114793 [doi].
36. O′Neill AJ, Lindsay JA, Gould K, Hinds J, Chopra I, (2009) Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother 53: 1701-1704 AAC.01309-08 [pii];10.1128/AAC.01309-08 [doi].
37. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, et al. (2003) Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49: 807-821.3599 [pii].
38. Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, et al. (2003) Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149: 2719-2732.
39. Liebeke M, Dorries K, Zuhlke D, Bernhardt J, Fuchs S, et al. (2011) A metabolomics and proteomics study of the adaptation of Staphylococcus aureus to glucose starvation. Mol Biosyst 7: 1241-1253 10.1039/c0mb00315h [doi].
40. Kohler C, Wolff S, Albrecht D, Fuchs S, Becher D, et al. (2005) Proteome analyses of Staphylococcus aureus in growing and non-growing cells: a physiological approach. Int J Med Microbiol 295: 547-565 S1438-4221(05)00128-1 [pii];10.1016/j.ijmm.2005.08.002 [doi].
41. Somerville GA, Proctor RA, (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73: 233-248 73/2/233 [pii];10.1128/MMBR.00005-09 [doi].
42. Pohl K, Francois P, Stenz L, Schlink F, Geiger T, et al. (2009) CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol 191: 2953-2963 JB.01492-08 [pii];10.1128/JB.01492-08 [doi].
43. Majerczyk CD, Dunman PM, Luong TT, Lee CY, Sadykov MR, et al. (2010) Direct targets of CodY in Staphylococcus aureus. J Bacteriol 192: 2861-2877 JB.00220-10 [pii];10.1128/JB.00220-10 [doi].
44. Dengler V, Meier PS, Heusser R, Berger-Bachi B, McCallum N, (2011) Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. BMC Microbiol 11: 16 1471-2180-11-16 [pii];10.1186/1471-2180-11-16 [doi].
45. Kuroda H, Kuroda M, Cui L, Hiramatsu K, (2007) Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 268: 98-105 FML568 [pii];-10.1111/j.1574-6968.2006.00568.x [doi].
46. Pinho MG, Errington J (2003) Dispersed mode of Staphylococcus aureus cell wall synthesis in the absence of the division machinery. Mol Microbiol 50: 871-881.3719 [pii].
47. Reynolds PE, (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8: 943-950.
48. Holmsen H, Daniel JL, Dangelmaier CA, Molish I, Rigmaiden M, et al. (1984) Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact platelets. Thromb Res 36: 419-428 0049-3848(84)90298-6 [pii].
49. Holmsen H, Rygh T, (1990) Chlorpromazine makes the platelet plasma membrane permeable for low-molecular weight substances and reduces ATP production. Biochem Pharmacol 40: 373-376.
50. Antignac A, Sieradzki K, Tomasz A, (2007) Perturbation of cell wall synthesis suppresses autolysis in Staphylococcus aureus: evidence for coregulation of cell wall synthetic and hydrolytic enzymes. J Bacteriol 189: 7573-7580 JB.01048-07 [pii];10.1128/JB.01048-07 [doi].
51. Fujimura T, Murakami K, (2008) Staphylococcus aureus clinical isolate with high-level methicillin resistance with an lytH mutation caused by IS1182 insertion. Antimicrob Agents Chemother 52: 643-647 AAC.00395-07 [pii];10.1128/AAC.00395-07 [doi].
52. Ornelas-Soares A, de Lencastre H, De Jonge BL, Tomasz A, (1994) Reduced methicillin resistance in a new Staphylococcus aureus transposon mutant that incorporates muramyl dipeptides into the cell wall peptidoglycan. J Biol Chem 269: 27246-27250.
53. Sobral RG, Ludovice AM, Gardete S, Tabei K, de Lencastre H, et al. (2003) Normally functioning murF is essential for the optimal expression of methicillin resistance in Staphylococcus aureus. Microb Drug Resist 9: 231-241 10.1089/107662903322286436 [doi].
54. Sobral RG, Ludovice AM, de Lencastre H, Tomasz A, (2006) Role of murF in cell wall biosynthesis: isolation and characterization of a murF conditional mutant of Staphylococcus aureus. J Bacteriol 188: 2543-2553 188/7/2543 [pii];-10.1128/JB.188.7.2543-2553.2006 [doi].
55. Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bachi B, (1999) The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc Natl Acad Sci U S A 96: 9351-9356.
56. De Jonge BL, Chang YS, Xu N, Gage D, (1996) Effect of exogenous glycine on peptidoglycan composition and resistance in a methicillin-resistant Staphylococcus aureus strain. Antimicrob Agents Chemother 40: 1498-1503.
57. Berger-Bachi B, Rohrer S, (2002) Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178: 165-171 10.1007/s00203-002-0436-0 [doi].
58. de Lencastre H, Wu SW, Pinho MG, Ludovice AM, Filipe S, et al. (1999) Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb Drug Resist 5: 163-175.
59. Lee SH, Jarantow LW, Wang H, Sillaots S, Cheng H, et al. (2011) Antagonism of chemical genetic interaction networks resensitize MRSA to beta-lactam antibiotics. Chem Biol 18: 1379-1389 S1074-5521(11)00330-9 [pii];10.1016/j.chembiol.2011.08.015 [doi].
60. Jenkins RE, Cooper R, (2012) Synergy between oxacillin and manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemother 67: 1405-1407 dks071 [pii];10.1093/jac/dks071 [doi].
61. Yam TS, Hamilton-Miller JM, Shah S, (1998) The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 42: 211-216.
62. Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JM, et al. (2004) Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int J Antimicrob Agents 23: 462-467 10.1016/j.ijantimicag.2003.09.027 [doi];S0924857904000366 [pii].
63. Pinho MG, de Lencastre H, Tomasz A, (2001) An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci U S A 98: 10886-10891 10.1073/pnas.191260798 [doi];191260798 [pii].
64. Leski TA, Tomasz A, (2005) Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. J Bacteriol 187: 1815-1824 187/5/1815 [pii];-10.1128/JB.187.5.1815-1824.2005 [doi].
65. Reed P, Veiga H, Jorge AM, Terrak M, Pinho MG, (2011) Monofunctional transglycosylases are not essential for Staphylococcus aureus cell wall synthesis. J Bacteriol 193: 2549-2556 JB.01474-10 [pii];10.1128/JB.01474-10 [doi].
66. Yao X, Lu CD, (2012) A PBP 2 mutant devoid of the transpeptidase domain abolishes spermine-beta-lactam synergy in Staphylococcus aureus Mu50. Antimicrob Agents Chemother 56: 83-91 AAC.05415-11 [pii];10.1128/AAC.05415-11 [doi].
67. Campbell J, Singh AK, Santa Maria JPJ, Kim Y, Brown S, et al. (2011) Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 6: 106-116 10.1021/cb100269f [doi].
68. Farha MA, Leung A, Sewell EW, D'Elia MA, Allison SE, et al. (2013) Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to beta-lactams. ACS Chem Biol 8: 226-233 10.1021/cb300413m [doi].
69. Atilano ML, Pereira PM, Yates J, Reed P, Veiga H, et al. (2010) Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A 107: 18991-18996 1004304107 [pii];10.1073/pnas.1004304107 [doi].
70. Brown S, Xia G, Luhachack LG, Campbell J, Meredith TC, et al. (2012) Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids. Proc Natl Acad Sci U S A 109: 18909-18914 1209126109 [pii];10.1073/pnas.1209126109 [doi].
71. Amaral L, Viveiros M, Molnar J, (2004) Antimicrobial activity of phenothiazines. In Vivo 18: 725-731.
72. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML, (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23: 99-139 23/1/99 [pii];10.1128/CMR.00042-09 [doi].
73. Hendricks O, Molnar A, Butterworth TS, Butaye P, Kolmos HJ, et al. (2005) In vitro activity of phenothiazine derivatives in Enterococcus faecalis and Enterococcus faecium. Basic Clin Pharmacol Toxicol 96: 33-36 PTOpto960105 [pii];-10.1111/j.1742-7843.2005.pto960105.x [doi].
74. Rahbar M, Mehrgan H, Hadji-nejad S, (2010) Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro. Basic Clin Pharmacol Toxicol 107: 676-679 PTO558 [pii];-10.1111/j.1742-7843.2010.00558.x [doi].
75. Sieradzki K, Tomasz A (1997) Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics. J Antimicrob Chemother 39 Suppl A: 47-51.
76. Ornelas-Soares A, de Lencastre H, de Jonge B, Gage D, Chang YS, et al. (1993) The peptidoglycan composition of a Staphylococcus aureus mutant selected for reduced methicillin resistance. J Biol Chem 268: 26268-26272.
77. Stranden AM, Ehlert K, Labischinski H, Berger-Bachi B, (1997) Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 179: 9-16.
78. Jung H, Pirch T, Hilger D, (2006) Secondary transport of amino acids in prokaryotes. J Membr Biol 213: 119-133 10.1007/s00232-006-0880-x [doi].
79. Bennett HJ, Pearce DM, Glenn S, Taylor CM, Kuhn M, et al. (2007) Characterization of relA and codY mutants of Listeria monocytogenes: identification of the CodY regulon and its role in virulence. Mol Microbiol 63: 1453-1467 MMI5597 [pii];10.1111/j.1365-2958.2007.05597.x [doi].
80. Schneider T, Senn MM, Berger-Bachi B, Tossi A, Sahl HG, et al. (2004) In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol Microbiol 53: 675-685 -10.1111/j.1365-2958.2004.04149.x [doi];MMI4149 [pii].
81. Giannouli S, Kyritsis A, Malissovas N, Becker HD, Stathopoulos C, (2009) On the role of an unusual tRNAGly isoacceptor in Staphylococcus aureus. Biochimie 91: 344-351 S0300-9084(08)00282-4 [pii];10.1016/j.biochi.2008.10.009 [doi].
82. Henkin TM, Glass BL, Grundy FJ, (1992) Analysis of the Bacillus subtilis tyrS gene: conservation of a regulatory sequence in multiple tRNA synthetase genes. J Bacteriol 174: 1299-1306.
83. Felden B, Vandenesch F, Bouloc P, Romby P, (2011) The Staphylococcus aureus RNome and its commitment to virulence. PLoS Pathog 7: e1002006 10.1371/journal.ppat.1002006 [doi].
84. Koyama N, Tokura Y, Munch D, Sahl HG, Schneider T, et al. (2012) The nonantibiotic small molecule cyslabdan enhances the potency of beta-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis. PLoS One 7: e48981 10.1371/journal.pone.0048981 [doi];PONE-D-12-08836 [pii].
85. Frenzel J, Arnold K, Nuhn P, (1978) Calorimetric, 13C NMR, and 31P NMR studies on the interaction of some phenothiazine derivatives with dipalmitoyl phosphatidylcholine model membranes. Biochim Biophys Acta 507: 185-197.
86. Moncelli MR, Becucci L, (1996) Effect of the molecular structure of more common amphiphilic molecules on their interactions with dioleoyl-phosphatidylcholine monolayers. Bioelectrochemistry and Bioenergetics 39: 227-234.
87. Nerdal W, Gundersen SA, Thorsen V, Hoiland H, Holmsen H, (2000) Chlorpromazine interaction with glycerophospholipid liposomes studied by magic angle spinning solid state (13)C-NMR and differential scanning calorimetry. Biochim Biophys Acta 1464: 165-175 S0005-2736(00)00125-5 [pii].
88. Thanacoody HK, (2007) Thioridazine: resurrection as an antimicrobial agent? Br J Clin Pharmacol 64: 566-574 BCP3021 [pii];-10.1111/j.1365-2125.2007.03021.x [doi].
89. Ordway D, Viveiros M, Leandro C, Arroz MJ, Amaral L, (2002) Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus. Int J Antimicrob Agents 20: 34-43 S0924857902001103 [pii].
90. Fordham WD, Gilvarg C, (1974) Kinetics of cross-linking of peptidoglycan in Bacillus megaterium. J Biol Chem 249: 2478-2482.